Faculty Bibliography

OBJECTIVES: The purpose of the study was to define an appropriate parameter for risk stratification and prognosis of patients undergoing stress echocardiography. BACKGROUND: Among stress echocardiography variables, peak wall-motion score index (WMSI) and ejection fraction (EF) have been shown to be independent and significant predictors of cardiovascular morbidity and mortality. Data on the impact and importance of each parameter in risk stratification and prognosis are limited. METHODS: We evaluated 1560 patients (59 +/- 13 years; 51% men) undergoing stress echocardiography (36% treadmill, 64% dobutamine). Peak WMSI was derived from the cumulative sum of 16 left ventricular segments divided by sum of visualized segments at peak stress. The ratio of peak WMSI to EF was calculated for the entire cohort. Based on this ratio and using the receiver operating characteristic curve, patients were divided into 3 groups: low- (< 1.9), intermediate- (1.9-3.1), and high- (> 3.1) risk subgroups. Follow-up (2.8 +/- 1.1 years) for confirmed myocardial infarction (n = 26) and cardiac death (n = 38) were obtained. RESULTS: Stress echocardiography effectively risk stratified patients into low- (0.7%/y), intermediate- (2.0%/y), and high- (4.4%/y) risk subgroups (P < .0001) based on the ratio of peak WMSI to EF. Cox proportional hazard model showed that risk stratification based on the ratio of peak WMSI to EF (global chi2 = 106.05; P < .0001) provided incremental value beyond that provided by risk stratification by peak WMSI (global chi2 = 79.23; P < .0001) or risk stratification by EF alone (global chi2 = 87.12; P < .0001). CONCLUSIONS: The ratio of peak WMSI to EF (stress function index) provides best incremental prognostic value and effectively risk stratifies patients into low-, intermediate-, and high-risk subgroups and is better than risk stratification by either peak WMSI or EF alone. The results of stress echocardiography should routinely combine peak WMSI and EF for effective risk stratification

Stress electrocardiographic (ECG) ST-segment depression is a prognostic marker of adverse cardiac outcomes in coronary artery disease. However, use of concurrent stress echocardiography (ECHO) has lead to concordant and discordant findings on stress electrocardiogram during stress studies. The prognostic value of stress ECHO in the setting of these stress ECG findings has not been previously evaluated. Outcomes of 1,268 patients (60 +/- 12 years old, 48% women) who had normal electrocardiograms and underwent stress ECHO were analyzed. ST-segment depression > or =1.5 mm in 2 contiguous leads on stress electrocardiogram and a wall motion score index of >1 on peak stress echocardiogram were considered abnormal. Events of nonfatal myocardial infarction (n = 18) and cardiac death (n = 32) were analyzed during follow-up (2.8 +/- 0.9 years). In 91 patients (7%) who had abnormal findings on stress electrocardiogram, 38 (41%) had an abnormal finding on stress echocardiogram and 4 had cardiac events (0.6% per year), and all who had a normal finding on stress echocardiogram had no events (n = 53, 59%, p = 0.01). Among 46 events (92%) with a normal finding on stress electrocardiogram, 30 (60%) showed a discordantly abnormal finding on stress echocardiogram (3.2% per year, p <0.01). Overall, the cohort that had normal findings on stress echocardiogram showed a lower event rate (72%, 16 events, 1.1% per year) compared with the cohort that had abnormal findings on stress echocardiogram (28%, 34 events, 3.6% per year, p <0.001), independent of stress ECG response. Peak wall motion score index (hazard ratio 2.55, p <0.001) and left ventricular ejection fraction (hazard ratio 0.99, p <0.001) were independent and incremental (global chi-square, p <0.001) prognostic markers by stress ECHO. In conclusion, a normal finding on stress echocardiogram confers a benign prognosis independent of the type of stress ECG response during stress studies. In addition, peak wall motion score index and ejection fraction by ECHO are stronger prognostic markers over stress electrocardiography in patients who are evaluated for coronary artery disease

We have recently developed and published 2 care pathways: 1 for the management of acute coronary syndrome and the other for acute heart failure. Our pathways are designed to optimize care for patients using clinical evidence models and to teach physicians in training consensus evaluation and management strategies. To implement our pathways to improve our patient care, we have developed unique admission and discharge forms derived from these pathways. These forms serve as reminders of key points of the pathways, as data collection devices, and most importantly as a health care agreement on discharge between patients and their healthcare providers